|
Symbol
|
LBBRDU | RMBW0V | DGUBKB | AEVQTQ | ADCDSQ | DJMBKB | RQORCH | DRRBKB | ADKWSQ | RMBTTV | Z0CK3Z | AEEGSQ | AHQETQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Worst of Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible with European Knock-In | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible |
|
Underlying
|
AstraZeneca Plc. / BioNTech SE / Novartis AG | BioNTech SE / Johnson & Johnson / Pfizer Inc. | Bayer AG / BioNTech SE | BioNTech SE / Pfizer Inc. / Roche PS | BioNTech SE / Merck KGaA / Pfizer Inc. | BioNTech SE / Johnson & Johnson / Pfizer Inc. | BioNTech SE / Moderna Inc. | BioNTech SE / Moderna Inc. | BioNTech SE / Moderna Inc. | BioNTech SE / Lonza Group N / Ypsomed Hldg. AG | BioNTech SE / Geberit AG / Lonza Group N | BioNTech SE / Pfizer Inc. | BioNTech SE / Johnson & Johnson / Pfizer Inc. |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
08.04.2027 | 01.02.2027 | 21.05.2027 | 24.05.2027 | 15.06.2027 | 30.06.2027 | 09.02.2027 | 17.02.2027 | 24.05.2027 | 20.09.2027 | 27.05.2027 | 08.09.2027 | 10.03.2028 |
| Bid | 95.90 | 101.30 | 98.10 | 97.48 | 96.38 | 97.58 | 102.97 | 102.24 | 102.92 | 99.10 | - | 97.07 | 95.74 |
| Ask | 96.90 | 102.30 | 98.90 | 98.28 | - | 98.38 | - | - | 103.75 | 100.10 | - | 97.87 | 96.54 |